BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 26571395)

  • 1. Inflammation drives thrombosis after Salmonella infection via CLEC-2 on platelets.
    Hitchcock JR; Cook CN; Bobat S; Ross EA; Flores-Langarica A; Lowe KL; Khan M; Dominguez-Medina CC; Lax S; Carvalho-Gaspar M; Hubscher S; Rainger GE; Cobbold M; Buckley CD; Mitchell TJ; Mitchell A; Jones ND; Van Rooijen N; Kirchhofer D; Henderson IR; Adams DH; Watson SP; Cunningham AF
    J Clin Invest; 2015 Dec; 125(12):4429-46. PubMed ID: 26571395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiologic and pathophysiologic roles of interaction between C-type lectin-like receptor 2 and podoplanin: partners from in utero to adulthood.
    Suzuki-Inoue K; Osada M; Ozaki Y
    J Thromb Haemost; 2017 Feb; 15(2):219-229. PubMed ID: 27960039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin.
    Suzuki-Inoue K
    Blood; 2019 Nov; 134(22):1912-1918. PubMed ID: 31778548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mice with a deficiency in CLEC-2 are protected against deep vein thrombosis.
    Payne H; Ponomaryov T; Watson SP; Brill A
    Blood; 2017 Apr; 129(14):2013-2020. PubMed ID: 28104688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-type lectin-like receptor 2 promotes hematogenous tumor metastasis and prothrombotic state in tumor-bearing mice.
    Shirai T; Inoue O; Tamura S; Tsukiji N; Sasaki T; Endo H; Satoh K; Osada M; Sato-Uchida H; Fujii H; Ozaki Y; Suzuki-Inoue K
    J Thromb Haemost; 2017 Mar; 15(3):513-525. PubMed ID: 28028907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin.
    Suzuki-Inoue K
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):175-181. PubMed ID: 31808911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CEACAM2 negatively regulates hemi (ITAM-bearing) GPVI and CLEC-2 pathways and thrombus growth in vitro and in vivo.
    Alshahrani MM; Yang E; Yip J; Ghanem SS; Abdallah SL; deAngelis AM; O'Malley CJ; Moheimani F; Najjar SM; Jackson DE
    Blood; 2014 Oct; 124(15):2431-41. PubMed ID: 25085348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RhoG protein regulates glycoprotein VI-Fc receptor γ-chain complex-mediated platelet activation and thrombus formation.
    Kim S; Dangelmaier C; Bhavanasi D; Meng S; Wang H; Goldfinger LE; Kunapuli SP
    J Biol Chem; 2013 Nov; 288(47):34230-34238. PubMed ID: 24106269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular Smooth Muscle Cells Stimulate Platelets and Facilitate Thrombus Formation through Platelet CLEC-2: Implications in Atherothrombosis.
    Inoue O; Hokamura K; Shirai T; Osada M; Tsukiji N; Hatakeyama K; Umemura K; Asada Y; Suzuki-Inoue K; Ozaki Y
    PLoS One; 2015; 10(9):e0139357. PubMed ID: 26418160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-associated fibroblasts promote venous thrombosis through podoplanin/CLEC-2 interaction in podoplanin-negative lung cancer mouse model.
    Shirai T; Tsukiji N; Sasaki T; Oishi S; Yokomori R; Takano K; Suzuki-Inoue K
    J Thromb Haemost; 2023 Nov; 21(11):3153-3165. PubMed ID: 37473844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential in vivo roles of the C-type lectin receptor CLEC-2: embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets.
    Suzuki-Inoue K; Inoue O; Ding G; Nishimura S; Hokamura K; Eto K; Kashiwagi H; Tomiyama Y; Yatomi Y; Umemura K; Shin Y; Hirashima M; Ozaki Y
    J Biol Chem; 2010 Aug; 285(32):24494-507. PubMed ID: 20525685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet glycoprotein VI and C-type lectin-like receptor 2 deficiency accelerates wound healing by impairing vascular integrity in mice.
    Wichaiyo S; Lax S; Montague SJ; Li Z; Grygielska B; Pike JA; Haining EJ; Brill A; Watson SP; Rayes J
    Haematologica; 2019 Aug; 104(8):1648-1660. PubMed ID: 30733265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant Hypo-Responsiveness to GPVI and CLEC-2 Agonists in Pre-Term and Full-Term Neonatal Platelets and following Immune Thrombocytopenia.
    Hardy AT; Palma-Barqueros V; Watson SK; Malcor JD; Eble JA; Gardiner EE; Blanco JE; Guijarro-Campillo R; Delgado JL; Lozano ML; Teruel-Montoya R; Vicente V; Watson SP; Rivera J; Ferrer-Marín F
    Thromb Haemost; 2018 Jun; 118(6):1009-1020. PubMed ID: 29695020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis.
    May F; Hagedorn I; Pleines I; Bender M; Vögtle T; Eble J; Elvers M; Nieswandt B
    Blood; 2009 Oct; 114(16):3464-72. PubMed ID: 19641185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The podoplanin-CLEC-2 axis inhibits inflammation in sepsis.
    Rayes J; Lax S; Wichaiyo S; Watson SK; Di Y; Lombard S; Grygielska B; Smith SW; Skordilis K; Watson SP
    Nat Commun; 2017 Dec; 8(1):2239. PubMed ID: 29269852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet CLEC-2: Roles Beyond Hemostasis.
    Suzuki-Inoue K; Tsukiji N; Shirai T; Osada M; Inoue O; Ozaki Y
    Semin Thromb Hemost; 2018 Mar; 44(2):126-134. PubMed ID: 28992650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heme activates platelets and exacerbates rhabdomyolysis-induced acute kidney injury via CLEC-2 and GPVI/FcRγ.
    Oishi S; Tsukiji N; Otake S; Oishi N; Sasaki T; Shirai T; Yoshikawa Y; Takano K; Shinmori H; Inukai T; Kondo T; Suzuki-Inoue K
    Blood Adv; 2021 Apr; 5(7):2017-2026. PubMed ID: 33843987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation on Syk Y342 is important for both ITAM and hemITAM signaling in platelets.
    Kostyak JC; Mauri B; Dangelmaier C; Vari HR; Patel A; Wright M; Reddy H; Tsygankov AY; Kunapuli SP
    J Biol Chem; 2022 Aug; 298(8):102189. PubMed ID: 35753354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CLEC-2-dependent platelet subendothelial accumulation by flow disturbance contributes to atherogenesis in mice.
    Tang C; Wang L; Sheng Y; Zheng Z; Xie Z; Wu F; You T; Ren L; Xia L; Ruan C; Zhu L
    Theranostics; 2021; 11(20):9791-9804. PubMed ID: 34815786
    [No Abstract]   [Full Text] [Related]  

  • 20. G6b-B inhibits constitutive and agonist-induced signaling by glycoprotein VI and CLEC-2.
    Mori J; Pearce AC; Spalton JC; Grygielska B; Eble JA; Tomlinson MG; Senis YA; Watson SP
    J Biol Chem; 2008 Dec; 283(51):35419-27. PubMed ID: 18955485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.